메뉴 건너뛰기




Volumn 92, Issue 2, 2011, Pages 491-498

Clinical T2-T3N0M0 esophageal cancer: The risk of node positive disease

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; EPIRUBICIN; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

EID: 79960953835     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.04.004     Document Type: Article
Times cited : (80)

References (17)
  • 3
    • 0036325365 scopus 로고    scopus 로고
    • Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus
    • DOI 10.1097/00000658-200208000-00005
    • N. Altorki, M. Kent, and C. Ferrara Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus Ann Surg 236 2002 177 183 (Pubitemid 34809536)
    • (2002) Annals of Surgery , vol.236 , Issue.2 , pp. 177-183
    • Altorki, N.1    Kent, M.2    Ferrara, C.3    Port, J.4
  • 4
    • 74049162396 scopus 로고    scopus 로고
    • Optimum lymphadenectomy for esophageal cancer
    • N.P. Rizk, H. Ishwaran, and T.W. Rice Optimum lymphadenectomy for esophageal cancer Ann Surg 251 2010 46 50
    • (2010) Ann Surg , vol.251 , pp. 46-50
    • Rizk, N.P.1    Ishwaran, H.2    Rice, T.W.3
  • 6
    • 30944465690 scopus 로고    scopus 로고
    • Adenocarcinoma of the esophagus and cardia: A review of the disease and its treatment
    • S.R. DeMeester Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment Ann Surg Oncol 13 2006 12 30
    • (2006) Ann Surg Oncol , vol.13 , pp. 12-30
    • Demeester, S.R.1
  • 8
    • 33847156303 scopus 로고    scopus 로고
    • Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis
    • DOI 10.1016/S1470-2045(07)70039-6, PII S1470204507700396
    • B. Burmeister, V. Gebski, B.M. Smithers, K. Foo, J. Zalcberg, J. Simes Australasian Gastro-Intestinal Trials Group Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in esophageal carcinoma: a meta-analysis Lancet Oncol 8 2007 226 234 (Pubitemid 46291702)
    • (2007) Lancet Oncology , vol.8 , Issue.3 , pp. 226-234
    • Gebski, V.1    Burmeister, B.2    Smithers, B.M.3    Foo, K.4    Zalcberg, J.5    Simes, J.6
  • 9
    • 49849089502 scopus 로고    scopus 로고
    • Total number of resected lymph nodes predicts survival in esophageal cancer
    • N.K. Altorki, X. Zhou, and B. Stiles Total number of resected lymph nodes predicts survival in esophageal cancer Ann Surg 248 2008 221 226
    • (2008) Ann Surg , vol.248 , pp. 221-226
    • Altorki, N.K.1    Zhou, X.2    Stiles, B.3
  • 10
    • 55449126942 scopus 로고    scopus 로고
    • The number of lymph nodes removed predicts survival in esophageal cancer: An international study on the impact of extent of surgical resection
    • C.G. Peyre, J. Hagen, and S.R. DeMeester The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg 248 2008 549 556
    • (2008) Ann Surg , vol.248 , pp. 549-556
    • Peyre, C.G.1    Hagen, J.2    Demeester, S.R.3
  • 12
    • 33745726677 scopus 로고    scopus 로고
    • Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    • MAGIC trial participants
    • D. Cunningham, W. Allum, S.P. Stenning MAGIC trial participants Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11 20
    • (2006) N Engl J Med , vol.355 , pp. 11-20
    • Cunningham, D.1    Allum, W.2    Stenning, S.P.3
  • 13
    • 41949119177 scopus 로고    scopus 로고
    • Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781
    • J. Tepper, M.J. Krasna, and D. Niedzwiecki Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol 26 2008 1086 1092
    • (2008) J Clin Oncol , vol.26 , pp. 1086-1092
    • Tepper, J.1    Krasna, M.J.2    Niedzwiecki, D.3
  • 14
    • 60849118127 scopus 로고    scopus 로고
    • Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction
    • M. Stahl, M.K. Walz, and M. Stuschke Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 2009 851 856
    • (2009) J Clin Oncol , vol.27 , pp. 851-856
    • Stahl, M.1    Walz, M.K.2    Stuschke, M.3
  • 15
    • 0035818048 scopus 로고    scopus 로고
    • Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction
    • J.S. Macdonald, S.R. Smalley, and J. Benedetti Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725 730
    • (2001) N Engl J Med , vol.345 , pp. 725-730
    • MacDonald, J.S.1    Smalley, S.R.2    Benedetti, J.3
  • 16
    • 33947534209 scopus 로고    scopus 로고
    • American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma
    • DOI 10.1200/JCO.2006.08.0101
    • N.P. Rizk, E. Venkatraman, and M.S. Bains American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma J Clin Oncol 25 2007 507 512 (Pubitemid 350002956)
    • (2007) Journal of Clinical Oncology , vol.25 , Issue.5 , pp. 507-512
    • Rizk, N.P.1    Venkatraman, E.2    Bains, M.S.3    Park, B.4    Flores, R.5    Tang, L.6    Ilson, D.H.7    Minsky, B.D.8    Rusch, V.W.9
  • 17
    • 58249129132 scopus 로고    scopus 로고
    • Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival
    • J.M. Donahue, F. Nichols, and Z. Li Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival Ann Thorac Surg 87 2009 392 399
    • (2009) Ann Thorac Surg , vol.87 , pp. 392-399
    • Donahue, J.M.1    Nichols, F.2    Li, Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.